Stock Market News for February 27, 2026
470 news published.
Earnings and quarterly results driving headlines
Globalstar (GSAT) released Q4 and full‑year 2025 results, with satellite‑service revenue and equipment backlog in focus for cash‑flow and growth signals.
ANI Pharmaceuticals (ANIP) reported record fourth‑quarter and full‑year 2025 results and reaffirmed 2026 guidance—an encouraging beat for specialty generics and contract manufacturing; read the earnings release.
NielsenIQ (NIQ) posted strong Q4 and full‑year results, offering consumer‑spending signals media and retail investors will parse; see the company statement.
Chart Industries (GTLS) reported Q4 and full‑year 2025 results, useful for gauging demand for cryogenic equipment in hydrogen and LNG projects.
Gemini (GEMI) scheduled Q4 and full‑year 2025 results for March 19, 2026—an early guidance season data point for growth and margin updates; details here.
Big‑tech partnerships, AI strategy and consumer tech moves
Amazon (AMZN) and OpenAI unveiled a strategic partnership that could reshape cloud‑AI dynamics and infrastructure spend—this tie‑up flags potential revenue lift for cloud services; read the announcement.
CarMax (KMX) launched a car shopping and selling experience in the ChatGPT App Store, a novel distribution channel that may lower search friction and alter digital‑lead economics.
Healthcare approvals, trials and high‑impact readouts
Eli Lilly (LLY) secured CHMP backing to expand Olumiant to adolescents with severe alopecia areata in the EU—regulatory momentum that could widen the addressable market; see the EMA update.
Pfizer (PFE) said PADCEV™ plus Keytruda® cut recurrence or death risk by nearly 50% in cisplatin‑eligible muscle‑invasive bladder cancer—data that could reshape standards of care and labeling.
Merck (MRK) reported that KEYTRUDA® plus paclitaxel improved overall survival in platinum‑resistant ovarian cancer, a meaningful clinical and commercial result.
Aardvark Therapeutics (AARD) announced a voluntary pause of its Phase 3 HERO trial in Prader‑Willi syndrome—material for timelines and valuation; investors will watch safety updates and next steps (company notice).
Energy, critical minerals and infrastructure
New Era Energy & Digital (NUAI) unveiled a 450 MW behind‑the‑meter generation plan with Thunderhead Energy and TURBINE‑X Energy—distributed capacity that could cut hosting costs and boost resiliency for industrial customers; read the project notice.
Blue Moon (BMM) agreed to acquire the Apex germanium and gallium mine from Teck, advancing North American critical‑minerals supply for semiconductors—investors should monitor permitting and capex plans (transaction notice).
Real estate, listings and investor events
AvalonBay Communities (AVB) and Camden Property Trust (CPT) will participate in the 2026 Citi Global Property CEO Conference, offering Q1 leasing and same‑store updates; AVB’s notice is here and CPT’s here.
SITE Centers (SITC) announced the sale of FlatAcres MarketCenter, a disposition that trims mall exposure and can redeploy capital; see the transaction notice.
Healthpeak Properties (DOC) filed a registration statement with the SEC for Janus Living, Inc.—a step toward monetization or a separate REIT strategy, important for REIT investors tracking portfolio recycling and IPO activity.
LGI Homes (LGIH) expanded in the Seattle market with the grand opening of Meadow Brook, a sign of geographic product‑market push in a high‑demand region; details here.
Brookfield Property Partners (BPY) completed its 2025 annual filings, closing an accounting and disclosure chapter that investors will scan for asset‑level detail and valuation commentary (filing).
Capital markets, financing and governance
Royal Caribbean Group (RCL) completed offerings of $1.25 billion notes due 2033 and $1.25 billion due 2038, extending maturities and strengthening cash runway; see the offering notice.
Franklin Street Properties (FSP) closed a $320 million secured credit facility to refinance debt and support strategic options.
Prothena (PRTA) announced an up to $100 million share repurchase plan, a capital‑allocation move that can support EPS and signal board confidence.
SOL Strategies (STKE) proposed a board transition, a governance development that can change strategic direction or investor engagement; read the notice.
M&A, media consolidation and strategic deals
Paramount (WBD) to acquire Warner Bros. Discovery in a tie‑up expected to reshape streaming economics and ad markets—see the transaction announcement.
Biotech, small‑cap reports and company updates
UroGen Pharma (URGN) reported durable complete responses for ZUSDURI™ across EORTC risk groups in recurrent NMIBC—efficacy that could affect commercial prospects and licensing talks (clinical release).
Celldex (CLDX) presented additional Phase 2 data for chronic spontaneous urticaria at AAAAI 2026, strengthening barzolvolimab’s profile and partnering potential (abstract).
Azitra (AZTR) announced full‑year 2025 results and business updates—investors should track revenue cadence and pipeline milestones in the update (release).
Cryo-Cell (CCEL) reported fiscal year results for the period ended Nov. 30, 2025—financials may influence valuation for stem‑cell storage companies; see the report.
OpGen (OPGN) announced a name change to CapForce Inc., a rebranding that often signals a strategic pivot or corporate reset (notice).
Mergers & listings, governance notices
FreeCast (CAST) rescheduled its direct listing to March 10, 2026—float timing remains relevant for potential supply shifts (filing).
What to watch next
Listen for earnings calls that shed light on revenue cadence and margin drivers. Track oncology regulatory rulings and trial pauses for program risk and label impacts. Watch capital actions—debt deals, filings and repurchases—for immediate effects on liquidity and float. And monitor major media M&A and cloud‑AI partnerships that could reset competitive dynamics and capital spending.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement